• PKM2 inhibitor (compound 3k) Workflow Guide

  2026-08-13

  Build reproducible glycolysis, viability, and macrophage-metabolism assays with PKM2 inhibitor (compound 3k). This guide connects oncology screening data with the USP7–PKM2 inflammation mechanism while separating established evidence from practical workflow recommendations.

• λ-PPase and the Phosphorylation Logic of BMAL1

  2026-08-12

  BMAL1 condensates create a new test case for phosphorylation biology. This thought-leadership guide shows how Lambda Protein Phosphatase can convert an observed phosphorylation signal into a controlled mechanistic and translational experiment.

• Cyclic Pifithrin-α Hydrobromide Workflows

  2026-08-12

  A scenario-based guide to using Cyclic Pifithrin-α hydrobromide (SKU A4477) for p53-dependent apoptosis, growth-arrest, and DNA-damage experiments. It covers solvent compatibility, controls, interpretation, cross-domain limitations, and practical vendor-selection criteria.

• Lyotropic Phases of Coil–Bottlebrush Diblocks

  2026-08-11

  This 2024 Macromolecules study examines how coil-block-bottlebrush diblock copolymers self-assemble in a homologous series of alkylimidazolium ionic liquids. Despite substantial changes in solvent selectivity with alkyl-chain length, the observed lyotropic phase behavior depends only weakly on ionic-liquid identity, suggesting that polymer architecture and effective composition can outweigh simple solvent-tuning expectations.

• EZ Cap™ Human PTEN mRNA Workflow Guide

  2026-08-10

  Build reproducible PTEN restoration experiments with Cap 1, poly(A)-tailed mRNA designed for efficient transient expression. This guide connects routine mRNA transfection to HA-LNP delivery, melanoma models, pathway assays, and practical troubleshooting.

• Aprotinin (Bovine Pancreatic Trypsin Inhibitor, BPTI) Guide

  2026-08-09

  A scenario-based guide to using Aprotinin (Bovine Pancreatic Trypsin Inhibitor, BPTI), SKU A2574, when protease activity complicates cell viability, proliferation, and cytotoxicity assays. It covers assay compatibility, preparation, dose interpretation, vendor selection, and the limits of translating fibrinolysis-related findings into cell-based research.

• FCCP as a Probe of Mitochondria–Peroxisome Signaling

  2026-08-08

  FCCP is more than an oxidative phosphorylation uncoupler: it can serve as a controlled energetic perturbation for investigating mitochondrial stress, HIF signaling, and mitochondria-derived pre-peroxisomes. This article connects FCCP assay design with the MARCH5–PEX3 pathway while separating established findings from testable experimental hypotheses.

• Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO)

  2026-08-07

  This EDTA-free protease inhibitor mixture helps limit endogenous proteolysis during protein extraction and sample preparation for assays such as Western blotting, co-immunoprecipitation, pull-downs, and kinase analysis. It is appropriate when preserving divalent cations matters, but it should not be treated as a substitute for EDTA when metalloprotease inhibition is required or as a complete phosphatase-inhibitor system.

• U 46619: Applied Platelet Aggregation & Vascular Modeling

  2026-08-07

  U 46619 (11,9 epoxymethano-prostaglandin H2) enables fine-tuned modeling of platelet function and vascular dynamics, setting a benchmark for reproducibility in cardiovascular and renal research. This guide demystifies experimental workflows, advanced applications, and troubleshooting strategies to help you unlock the full potential of U 46619 from APExBIO.

• MHY1485: Reliable mTOR Activator for Autophagy Assays (SKU B

  2026-08-06

  This article guides biomedical researchers and lab technicians through real-world scenarios where MHY1485 (SKU B5853) excels as an mTOR activator, particularly in autophagy inhibition and cell viability workflows. Drawing on validated literature and protocol insights, we highlight how MHY1485 from APExBIO supports reproducible, interpretable results while addressing common lab challenges.

• Regorafenib Suppresses Melanoma via RRM2/ERK-E2F3 Pathway Mo

  2026-08-06

  This study demonstrates that Regorafenib (BAY 73-4506) inhibits melanoma progression by downregulating RRM2 and suppressing ERK/E2F3 signaling, leading to reduced cell proliferation, invasion, and enhanced apoptosis. These findings clarify key mechanistic aspects of Regorafenib's antitumor effects and offer new directions for targeted melanoma research.

• VE-821 ATR Kinase Inhibitor: Optimizing DNA Damage Research

  2026-08-05

  VE-821 stands out as a highly selective ATR kinase inhibitor, enabling precise dissection of DNA repair pathways and radiosensitization workflows. This article translates leading-edge research into actionable protocols, advanced troubleshooting strategies, and new cross-domain opportunities for DNA damage response studies.

• G-15: Transforming GPR30 Antagonism for Translational Resear

  2026-08-05

  G-15, a potent and selective G protein-coupled estrogen receptor antagonist, is redefining the experimental and translational toolkit available to researchers decoding estrogen signaling. By bridging rigorous mechanistic insight with strategic guidance for translational workflows, this article delivers a fresh perspective on GPR30’s emerging roles in pain, neurobiology, and cellular signaling—supported by recent high-impact findings and advanced assay protocols.

• MT2A Modulates Apoptosis and Proliferation in HL60 Cells

  2026-08-04

  This study investigates the functional effects of MT2A expression in HL60 leukemia cells, revealing that MT2A upregulation promotes apoptosis and cell cycle arrest, while its inhibition enhances proliferation. These findings clarify MT2A's involvement in acute myeloid leukemia (AML) biology and suggest its relevance as a regulatory node in the NF-κB signaling pathway.

• WP1066: Advancing JAK2/STAT3 Inhibition in Oncology Research

  2026-08-04

  Explore how WP1066, a potent JAK2/STAT3 inhibitor, enables high-precision cancer research and uncovers new insights into tumor signaling and therapeutic strategies. This article delivers unique mechanistic depth and strategic assay guidance.

449 records 8/30 page Previous Next First page 上5页 678910 下5页 Last page